Reinhard E. Voll

Dec 20, 2023 | ard.bmj.com | Kevin L. Winthrop |Philip Mease |Andreas Kerschbaumer |Reinhard E. Voll

Handling editor David S PisetskyTwitter @ProfJohnIsaacs, @CarolineOspelt, @StefanSiebert1Contributors All authors contributed to the study design, data collection, discussion and critical revision of the manuscript. Funding The Advances in Targeted Therapies meeting was supported by: AbbVie, AnaptysBio, BMS, Chugai, Eli Lilly, Galapagos, GSK, Janssen, Mitsubishi, Novartis, and Pfizer.